Zhang, Xiaoqun <br/><br/>
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.  [electronic resource] 

 -  Neuropharmacology  Jun 2008 
 - 1143-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2008.03.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--therapeutic use<br/>Autoradiography--methods<br/>Behavior, Animal<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism<br/>Cocaine--analogs & derivatives<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Feedback--physiology<br/>Functional Laterality<br/>Gene Expression Regulation--drug effects<br/>Levodopa--therapeutic use<br/>Oxidopamine--toxicity<br/>Parkinson Disease--drug therapy<br/>Peptide Fragments--pharmacokinetics<br/>Quinolines--pharmacology<br/>Radioisotopes--pharmacokinetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Neurokinin-3--physiology<br/>Serine--metabolism<br/>Substance P--analogs & derivatives<br/>Sympatholytics--toxicity<br/>Tyrosine 3-Monooxygenase--metabolism